Our services
Biomarker analysis
Quantitative insights supporting translational and clinical decisions
Discovery bioanalysis
Early-stage profiling from small molecules to complex biologics
In vitro ADMET studies with predictive and regulatory value
Drug metabolism & ADMET
Flow cytometry & haematology
Specialised platforms for immunophenotyping and blood analysis
Validated methods and compliant data packages ready for submission
Property characterisation to de-risk candidate progression
Regulatory bioanalysis
Physicochemical assessment
Streamline your development timeline. Our expert teams apply advanced analytical techniques and rigorous method validation to reduce risk and accelerate progress, from exploratory studies to compliant submissions.
6+
Platforms
End-to-end
Coverage
Biomarker analysis
Pharmidex offers comprehensive cytokine analysis services across multiple therapeutic areas, including respiratory disease, autoimmune conditions, metabolic disorders and toxicology.
We provide precise, reliable data to support drug efficacy, safety and immune modulation studies. Our state-of-the-art multiplex platforms deliver quantification and characterisation of cytokines from a wide range of biological matrices to support both preclinical and clinical programmes.
Discovery bioanalysis
Pharmidex bioanalysts have supported many thousands of non-clinical studies for hundreds of clients, with extensive experience across bioanalytical techniques and the ADMET field — gained from both the CRO environment and leading pharmaceutical R&D organisations. Our laboratories are equipped with UHPLC systems linked to high-resolution QTof and triple quadrupole mass spectrometers, delivering precise and reliable data across all stages of drug discovery and development.
Drug metabolism
Using UHPLC coupled with high-resolution accurate mass spectrometry, our scientific experts conduct in-depth drug metabolism studies, resolving high clearance issues, characterising cross-species metabolite profiles, and investigating potential reactive metabolism liabilities.
In Vitro ADMET
Using UHPLC coupled with high-resolution accurate mass spectrometry, our scientific experts conduct in-depth drug metabolism studies, resolving high clearance issues, characterising cross-species metabolite profiles, and investigating potential reactive metabolism liabilities.
Flow cytometry
Pharmidex's flow cytometry service is powered by the Attune NxT Acoustic Flow Cytometer with CytKick Max Autosampler, a high-throughput benchtop cytometer with acoustic focusing and 12 fluorescence channels.
Integrated with our established in vivo models, biomarker analytics and imaging services, this capability delivers unmatched depth and speed across immunophenotyping, functional immune assays, drug screening and beyond.
Haematology
Pharmidex offers advanced Clinical Pathology services powered by the Siemens Healthineers ADVIA 2120 haematology analyser, delivering precise and reliable results across a broad range of biological parameters to support drug development and translational research.
Regulatory bioanalysis
Our Regulatory Bioanalysis service provides GLP/GCP-compliant analytical services for preclinical and clinical development, covering PK, TK and biomarkers.
Physicochemical assessment
An understanding of simple physicochemical properties can help drive the lead identification and optimisation phases of drug discovery.
Contact Us
Address
167-169 Great Portland Street, Fifth Floor, London, W1W 5PF
Contacts
Email: bd@pharmidex.com
